# Volitionrx Ltd: filings

VNRX · NYSE · CIK 93314 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vnrx.md) · [Financials](/companies/vnrx/financials.md) · [Filings](/companies/vnrx/filings.md) · [Insiders](/companies/vnrx/insiders.md)

## Reports and events: 265 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 567, 8-K 141, 10-Q 52, 424B5 28, CORRESP 26, 3 24, UPLOAD 20, 10-K 17, EFFECT 16, D 14, DEF 14A 14, 5 13, SC 13D/A 13, SC 13G/A 12, 424B3 11, S-3 11, SCHEDULE 13G/A 11, PRE 14A 10, S-8 10, 8-K/A 8, SC 13G 8, S-1/A 6, S-3/A 5, SC 13D 5, 4/A 4, S-1 4, DEFA14A 3, 10-KT/A 2, 10-Q/A 2, 10-K/A 1, 10-KT 1, 3/A 1, 424B4 1, 425 1, 8-A12B 1, AW 1, CERTNYS 1, D/A 1, NT 10-K 1, POS AM 1, RW 1, RW WD 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-25 | 17:00 ET | [8-K](/filings/0001477932-26-005804.md) | 3.02 Unregistered sale of equity | 0001477932-26-005804 |
| 2026-09-16 | 17:30 ET | [SCHEDULE 13D/A](/filings/0001493152-26-042962.md) | Ownership report, active investor, amended | 0001493152-26-042962 |
| 2026-09-15 | 17:00 ET | [8-K](/filings/0001477932-26-005620.md) | 3.02 Unregistered sale of equity | 0001477932-26-005620 |
| 2026-09-14 | 16:45 ET | [8-K](/filings/0001477932-26-005578.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-005578 |
| 2026-09-04 | 17:29 ET | [SCHEDULE 13D](/filings/0001493152-26-041611.md) | Ownership report, active investor | 0001493152-26-041611 |
| 2026-09-02 | 16:45 ET | [8-K](/filings/0001477932-26-005359.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-26-005359 |
| 2026-09-02 | 21:54 ET | [8-K](/filings/0001477932-26-005351.md) | 3.02 Unregistered sale of equity | 0001477932-26-005351 |
| 2026-08-24 | 17:00 ET | [8-K](/filings/0001477932-26-005251.md) | 3.02 Unregistered sale of equity | 0001477932-26-005251 |
| 2026-08-13 | 16:40 ET | [10-Q](/filings/0001477932-26-004995.md) | Quarterly report, period 2026-06-30 | 0001477932-26-004995 |
| 2026-08-13 | 16:32 ET | [8-K](/filings/0001477932-26-004991.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-004991 |
| 2026-08-07 | 17:00 ET | [8-K](/filings/0001477932-26-004778.md) | 3.02 Unregistered sale of equity | 0001477932-26-004778 |
| 2026-07-21 | 16:15 ET | [8-K](/filings/0001477932-26-004421.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-26-004421 |
| 2026-06-18 | 17:00 ET | [8-K](/filings/0001477932-26-003932.md) | 3.02 Unregistered sale of equity | 0001477932-26-003932 |
| 2026-06-10 | 19:04 ET | [8-K](/filings/0001477932-26-003740.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-003740 |
| 2026-06-02 | 16:21 ET | [DEF 14A](/filings/0001477932-26-003587.md) | Proxy statement, period 2026-07-17 | 0001477932-26-003587 |
| 2026-05-22 | 17:00 ET | [8-K](/filings/0001477932-26-003416.md) | 1.01 Entry into a material agreement | 0001477932-26-003416 |
| 2026-05-15 | 16:45 ET | [8-K](/filings/0001477932-26-003241.md) | 5.02 Departure or appointment of officers or directors | 0001477932-26-003241 |
| 2026-05-14 | 16:21 ET | [10-Q](/filings/0001477932-26-003128.md) | Quarterly report, period 2026-03-31 | 0001477932-26-003128 |
| 2026-05-14 | 16:18 ET | [8-K](/filings/0001477932-26-003126.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-003126 |
| 2026-04-30 | 16:45 ET | [10-K/A](/filings/0001477932-26-002685.md) | Annual report, amended, period 2025-12-31 | 0001477932-26-002685 |
| 2026-04-28 | 17:00 ET | [8-K](/filings/0001477932-26-002619.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-26-002619 |
| 2026-04-23 | 08:45 ET | [8-K](/filings/0001477932-26-002472.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-002472 |
| 2026-04-17 | 17:00 ET | [8-K](/filings/0001477932-26-002373.md) | 8.01 Other events | 0001477932-26-002373 |
| 2026-04-01 | 16:30 ET | [8-K](/filings/0001477932-26-001940.md) | 5.07 Shareholder vote results | 0001477932-26-001940 |
| 2026-03-31 | 16:13 ET | [10-K](/filings/0001477932-26-001832.md) | Annual report, period 2025-12-31 | 0001477932-26-001832 |
| 2026-03-31 | 16:12 ET | [8-K](/filings/0001477932-26-001830.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-001830 |
| 2026-02-20 | 17:15 ET | [8-K](/filings/0001477932-26-000955.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-26-000955 |
| 2026-02-11 | 17:05 ET | [DEF 14A](/filings/0001477932-26-000757.md) | Proxy statement, period 2026-02-10 | 0001477932-26-000757 |
| 2026-02-09 | 17:26 ET | [8-K](/filings/0001477932-26-000714.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-000714 |
| 2026-01-08 | 17:28 ET | [8-K](/filings/0001477932-26-000107.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-26-000107 |
| 2025-12-11 | 17:00 ET | [8-K](/filings/0001477932-25-008932.md) | 5.02 Departure or appointment of officers or directors | 0001477932-25-008932 |
| 2025-11-13 | 16:18 ET | [10-Q](/filings/0001477932-25-008186.md) | Quarterly report, period 2025-09-30 | 0001477932-25-008186 |
| 2025-11-13 | 16:12 ET | [8-K](/filings/0001477932-25-008182.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-25-008182 |
| 2025-11-13 | 16:06 ET | [8-K/A](/filings/0001477932-25-008179.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-25-008179 |
| 2025-11-10 | 17:05 ET | [8-K/A](/filings/0001477932-25-008019.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-25-008019 |
| 2025-11-07 | 17:30 ET | [8-K](/filings/0001477932-25-007984.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-25-007984 |
| 2025-10-14 | 17:12 ET | [8-K](/filings/0001477932-25-007544.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-007544 |
| 2025-08-15 | 17:16 ET | [10-Q/A](/filings/0001477932-25-005992.md) | Quarterly report, amended, period 2025-06-30 | 0001477932-25-005992 |
| 2025-08-14 | 16:54 ET | [10-Q](/filings/0001477932-25-005923.md) | Quarterly report, period 2025-06-30 | 0001477932-25-005923 |
| 2025-08-14 | 16:45 ET | [8-K](/filings/0001477932-25-005919.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-25-005919 |
| 2025-08-04 | 16:21 ET | [8-K](/filings/0001477932-25-005422.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-005422 |
| 2025-06-20 | 16:06 ET | [8-K](/filings/0001477932-25-004721.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-25-004721 |
| 2025-05-15 | 17:27 ET | [10-Q](/filings/0001477932-25-003853.md) | Quarterly report, period 2025-03-31 | 0001477932-25-003853 |
| 2025-05-15 | 17:26 ET | [8-K](/filings/0001477932-25-003852.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-25-003852 |
| 2025-04-29 | 16:18 ET | [DEF 14A](/filings/0001477932-25-003069.md) | Proxy statement, period 2025-04-24 | 0001477932-25-003069 |
| 2025-04-22 | 17:16 ET | [8-K](/filings/0001477932-25-002897.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001477932-25-002897 |
| 2025-04-04 | 17:22 ET | [8-K](/filings/0001477932-25-002475.md) | 7.01 Regulation FD disclosure | 0001477932-25-002475 |
| 2025-04-04 | 17:20 ET | [S-1](/filings/0001477932-25-002474.md) | Registration statement | 0001477932-25-002474 |
| 2025-03-31 | 16:18 ET | [10-K](/filings/0001477932-25-002231.md) | Annual report, period 2024-12-31 | 0001477932-25-002231 |
| 2025-03-31 | 16:10 ET | [8-K](/filings/0001477932-25-002227.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-25-002227 |

Page 1 of 6. [Older](/companies/vnrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:01 ET. No prices; not investment advice.